Cancer. Malignant neoplasms of ill-defined, secondary and unspecified sites
Conditions
Interventions
Intervention 1: The intervention group: a total of 40 patients will receive the training in the intervention group. The intervention will be conducted in a group format across 4 subgroups of 10 indivi
Sponsors
Shahroud University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: women with breast cancer Participants aged between 18 and 60 years Ability to communicate effectively Being in good mental and physical health Confirmed diagnosis by a physician
Exclusion criteria
Exclusion criteria: Concurrent participation in other studies related to self-advocacy Use of psychoactive medications or receiving psychotherapy prescribed by a physician during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-advocacy. Timepoint: prior to the intervention, immediately after the intervention, 2 weeks after the intervention, 1 month after the intervention. Method of measurement: The Patient Self-Advocacy Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Patients’ anxiety levels will be assessed as a secondary outcome before the intervention, immediately after the intervention, 2 weeks after the intervention, 1 month after the intervention. Method of measurement: Patients’ anxiety levels will also be assessed using the Hospital Anxiety and Depression Scale (HADS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rahmani Iniolia
Shahroud University of Medical Sciences
Outcome results
None listed